Skip to main content
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.630
+0.340 (14.85%)
Apr 28, 2025, 9:31 AM EDT - Market open

China SXT Pharmaceuticals Revenue

China SXT Pharmaceuticals had revenue of $829.49K in the half year ending September 30, 2024, a decrease of -31.35%. This brings the company's revenue in the last twelve months to $1.82M, up 6.78% year-over-year. In the fiscal year ending March 31, 2024, China SXT Pharmaceuticals had annual revenue of $1.93M, down -2.19%.

Revenue (ttm)
$1.82M
Revenue Growth
+6.78%
P/S Ratio
0.35
Revenue / Employee
$24,245
Employees
75
Market Cap
36.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.93M-43.18K-2.19%
Mar 31, 20231.97M-630.60K-24.23%
Mar 31, 20222.60M-2.18M-45.53%
Mar 31, 20214.78M-384.70K-7.45%
Mar 31, 20205.16M-1.85M-26.38%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

SXTC News

More News